GERON ANNOUNCES IMPROVED PRODUCTION METHOD FOR HUMAN EMBRYONIC STEM CELL-DERIVED ISLET CELLS

Source: Geron Corporation

Menlo Park, CA — January 27, 2006 -- Geron Corporation announced the presentation of a new production protocol to differentiate islet cells from human embryonic stem cells (hESCs) for the treatment of diabetes.